Sen-Jam Pharmaceutical
Own a stake for health equality; affordable and accessible for all
Overview
Raised: $312,093
Total Commitments ($USD)
Platform
StartEngine
Start Date
10/13/2022
Close Date
01/11/2023
Min. Goal
$9,996
Max. Goal
$3,992,792
Min. Investment
$588
Security Type
Equity - Common
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$7.35
Pre-Money Valuation
$69,979,019
Rolling Commitments ($USD)
Status
Funded
Reporting Date
01/31/2023
Days Remaining
Funded
% of Min. Goal
3,122%
% of Max. Goal
8%
Likelihood of Max
Funded
Avg. Daily Raise
$3,468
# of Investors
83
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2C
Margin
Medium
Capital Intensity
Low
Sen-Jam Pharmaceutical, with a valuation of $70 million, is raising funds on StartEngine. The pharmaceutical company makes highly accessible, safe, and affordable drugs that work. The drugs of Sen-Jam Pharmaceutical combine NSAIDs and antihistamines to prevent inflammation and associated pain. Sen-Jam Pharmaceutical is majorly targeting opioid withdrawal, alcohol hangover prevention, and COVID-19 therapeutic. Jim Iversen and Jackie Iversen founded Sen-Jam Pharmaceutical in August 2017. The current crowdfunding campaign has a minimum target of $9,996 and a maximum target of $3,992,791.95. The campaign proceeds will be used to complete the COVID Phase II trial, seek emergency use authorization, complete the Phase II trial for the alcohol hangover product, and begin the Phase II trial for opioid withdrawal.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-417,348 |
$-336,824 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$64,694 |
$12,255 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$560,194 |
$505,755 |
|
Short-Term Debt |
$47,033 |
$15,292 |
|
Long-Term Debt |
$857,159 |
$417,114 |
|
Total Liabilities |
$904,192 |
$432,406 |
Financials as of: 10/13/2022
Create a free account today to gain access to KingsCrowd analytics.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of Sen-Jam Pharmaceutical? Create your account today to claim this raise page.